Viewing StudyNCT00131118



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00131118
Status: COMPLETED
Last Update Posted: 2017-06-01
First Post: 2005-08-15

Brief Title: Zoledronic Acid in Children 1 -17 Years With Severe Osteogenesis Imperfecta
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-07
Start Date Type: None
Primary Completion Date: 2007-05
Primary Completion Date Type: ACTUAL
Completion Date: 2007-05
Completion Date Type: ACTUAL
First Submit Date: 2005-08-15
First Submit QC Date: August 15 2005
Study First Post Date: 2005-08-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-05-31
Last Update Post Date: 2017-06-01
Last Update Post Date Type: ACTUAL